青建國際(01240.HK)獲授兩份建築工程合約 總合約額預計5.08億港元
格隆匯6月6日丨青建國際(01240.HK)發佈公吿,集團最近獲授兩份香港建築工程合約,即:(i)建築署於2024年4月3日已就於灣仔愛羣道建造一間擁有12間教室的特殊學校的總承包工程(為混凝土組裝合成(“組裝合成”)項目)向公司的間接全資附屬公司授出一份主要合約(“特殊學校合約”);及(ii)香港房屋委員會於2024年6月4日已就位於深水埗荔枝角道的公營房屋發展項目建設向公司另一間間接全資附屬公司授出另一份地基合約(“公營房屋合約”,統稱“該等合約”)。
倘若完成該等合約中所述的所有建築工程,兩份該等合約的總合約額預計約為5.08億港元(包括或有款項)。特殊學校合約預期將於2027年1月底前完成,而公營房屋合約預期將於2025年7月底前完成。由於合約額包含或有款項,其未必會實現,故集團自該等合約獲得的實際合約額未必等於合約額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.